A recent study looked at 13 research papers with 4275 patients
[1], [2], [3], [4] A 2021 retrospective study conducted at the Institute for Hormonal Balance in Orlando, Florida, that evaluated the use of BPC 157, alone or in combination with thymosin-beta-4 (TB4), indicates in its methodology that no human clinical trials evaluating the use of BPC 157 to help with knee pain have been published (see Table 1)
It is known for its potent anti-inflammatory properties and its ability to promote cell migration to sites of injury
Surgery Avoidance: 50-70% of PRP-treated partial tears avoid surgery at 2-year follow-up
Results typically last 1-2 weeks, but this can vary from person to person
Always verify compatibility with the prescribed drug